Market Research Reports and Industry Reports

Hepatitis C Market & Forecast, Hepatitis C Pipeline Drugs Sales & Forecast, Clinical Trials - Global

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • PURCHASE BY
    SECTION

Market for Hepatitis C drugs has grown with a phenomenal rate of more than US$ 13 Billion, in the year 2014 compared to 2013. In the last two years a couple of new drugs have been introduced in the market which has become a huge success and they have captured maximum market share of the Hepatitis C market. Gilead currently dominates the multi-billion dollar Hepatitis C market, but AbbVie has been trying to increase its market share since U.S. regulators approved the marketing of its Viekira Pak. Drug makers are already focusing on introducing new drugs in the market as several drugs are standing in the pipeline. Hepatitis C Drugs is anticipated to be a rosy market for future period.

This is 3rd edition report on Hepatitis C Drugs Industry by Renub Research. Report titled “Hepatitis C Market & Forecast, Hepatitis C Pipeline Drugs Sales & Forecast, Clinical Trials - Global” provides a comprehensive assessment of the fast-evolving, high-growth of Hepatitis sector. This 87 page report with 18 Figures and 1 Table studies the Hepatitis C Drug Market Landscape.

1. Hepatitis C Drugs Market & Forecast (Chapter 2)
2. Hepatitis C Approved Drugs Sales & Forecast (Chapter 3)
3. Hepatitis C – Pipeline Drugs Sales & Forecast (Chapter 4)
4. Hepatitis C Deals & Acquisitions (Chapter 5)
5. Hepatitis C – Company Wise Clinical Trial Analysis (Chapter 6)

Hepatitis C – Approved Drugs Sales & Forecast (To 2020) (Chapter No. 3)

1. Pegasys
2. Pegintron
3. Incivek
4. Victrelis
5. Olysio
6. Sovaldi/Harvoni
7. HCV Franchise
8. Viekira Pak

Hepatitis C – Pipeline Drugs Sales Forecast (To 2020) (Chapter No. 4)

1. Drug A (Merck & Co. Inc.)
2. Drug B (Merck & Co. Inc.)
3. Drug C (Bristol-Myers Squibb)

Hepatitis C – Company Wise Clinical Trial Analysis (Chapter No.5)

1. AbbVie
2. Bristol-Myers Squibb (BMS)
3. Gilead Sciences
4. Merck & Co. Inc.
5. Tibotec/Janssen Therapeutics

Data Sources

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts.

Primary sources include industry surveys and telephone interviews with industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases.

1. Executive Summary
 
 2. Hepatitis C Drugs – Market & Forecast
 
 3. Hepatitis C – Approved Drugs Sales & Forecast
 3.1 Pegasys Sales & Forecast
 3.2 Pegintron Sales & Forecast
 3.3 Incivek Sales
 3.4 Victrelis Sales & Forecast
 3.5 Olysio Sales & Forecast
 3.6 Sovaldi / Harvoni Sales & Forecast
 3.7 HCV Franchise Sales & Forecast
 3.8 Viekira Pak Sales & Forecast
 
 4. Hepatitis C - Pipeline Drugs Sales Forecast
 4.1 Drug A of (Merck & Co. Inc.)
 4.2 Drug B of (Merck & Co. Inc.)
 4.3 Drug C of (Bristol-Myers Squibb)
 
 5. Hepatitis C – Deals & Acquisitions
 
 6. Hepatitis C – Company Wise Clinical Trials Analysis
 6.1 AbbVie – Clinical Trials
 6.1.1 Phase III
 6.1.2 Phase II
 6.1.3 Phase I
 6.2 Bristol-Myers Squibb (BMS) – Clinical Trials
 6.2.1 Phase III
 6.2.2 Phase II
 6.3 Gilead Sciences – Clinical Trials
 6.3.1 Phase II
 6.4 Merck & Co. Inc. – Clinical Trials
 6.4.1 Phase IV
 6.4.2 Phase III
 6.4.3 Phase II
 6.4.4 Phase I
 6.5 Tibotec / Janssen Therapeutics – Clinical Trials
 6.5.1 Phase IV
 6.5.2 Phase III
 6.5.3 Phase II
 6.5.4 Phase I


List Of Tables

Table 5 1: Hepatitis C – Deals & Acquisitions in the anti-HCV Drug Space, 2004 – 2012


List Of Figures

Figure 2 1: Global – Hepatitis C Drug Market (Million US$), 2010 – 2014
 Figure 2 2: Global – Forecast for Hepatitis C Drug Market (Million US$), 2015 – 2020
 Figure 3 1: Global – Pegasys Sales (Million US$), 2005 – 2014
 Figure 3 2: Global – Forecast for Pegasys Sales (Million US$), 2015 – 2020
 Figure 3 3: Global – Pegintron Sales (Million US$), 2010 – 2014
 Figure 3 4: Global – Forecast for Pegintron Sales (Million US$), 2015 – 2020
 Figure 3 5: Global – Incivek Sales (Million US$), 2011 – 2014
 Figure 3 6: Global – Victrelis Sales & Forecast (Million US$), 2011 – 2015
 Figure 3 7: Global – Olysio Sales (Million US$), 2013 – 2014
 Figure 3 8: Global – Forecast for Olysio Sales (Million US$), 2015 – 2020
 Figure 3 9: Global – Sovaldi/Harvoni Sales (Million US$), 2013 – 2014
 Figure 3 10: Global – Forecast for Sovaldi/Harvoni Sales (Million US$), 2015 – 2020
 Figure 3 11: Global – HCV Franchise Sales & Forecast (Million US$), 2014 – 2020
 Figure 3 12: Hepatitis C Drugs – Viekira Pak, Sovaldi & Harvoni Initial Prescription (Number), 2013, 2014
 Figure 3 13: Global – Viekira Pak Sales & Forecast (Million US$), 2014 – 2020
 
 Figure 4 1: Global – Forecast for Vaniprevir (MK-7009) Sales (Million US$), 2015 – 2020
 Figure 4 2: Global – Forecast for Grazoprevir/Elbasvir (MK-5172 + MK-8742) Sales (Million US$), 2016 – 2020
 Figure 4 3: Global – Forecast for PEG-Interferon Lambda Sales (Million US$), 2015 – 2020


2016-2021 Europe Hepatitis Markers Testing Market: Hospitals, Blood Banks, Public Health Labs, Commercial Labs, Physician Offices--Supplier Shares and Country Sales Segment Forecasts for 10 Immunodiagnostic and NAT Procedures

Complete report $6,900.  DataPack (test volumes, sales forecasts, supplier shares) $4,500.The report presents a detailed analysis of the Hepatitis diagnostics market in Europe, (France, Germany, Italy, Spain, UK).  Current scientific

USD 6900View Report

2016-2021 Global Hepatitis Markers Testing Market: Hospitals, Blood Banks, Public Health Labs, Commercial Labs, Physician Offices--Supplier Shares and Country Sales Segment Forecasts for 10 Immunodiagnostic and NAT Procedures--France, Germany, Italy, Japan, Spain, UK, US

The report presents a detailed analysis of the Hepatitis diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Hepatitis definition,

USD 9500View Report

2017 US Hepatitis A, B, C, D, E Diagnostics Market: Blood Banks, Commercial Labs, Hospitals, Physician Offices, Public Health Labs--Supplier Shares, Competitive Strategies, Country Market Segment Volume and Sales Forecasts for Immunodiagnostic and NAT Procedures, Innovative Technologies, Instrumentation Review

Complete report $3,900.  DataPack (test volumes, sales forecasts, supplier shares) $2,500.The report presents a detailed analysis of the Hepatitis diagnostics market in the US. Current scientific views on the Hepatitis

USD 3900View Report

Japan Medical Dynamic Marketing, Inc. Company Profile- Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis

Japan Medical Dynamic Marketing, Inc. Company Profile is a complete analysis of the companys operations, strategies, outlook and historic performance. The research work analyzes key strategies in current market

USD 200View Report

Europe Solar Concentrated Photovoltaic Market Report 2016

Notes:Sales, means the sales volume of Solar Concentrated PhotovoltaicRevenue, means the sales value of Solar Concentrated PhotovoltaicThis report studies sales (consumption) of Solar Concentrated Photovoltaic in Europe market, especially in

USD 3900View Report

Global Paints & Coatings Used Shellac Market Professional Survey Report 2016

Notes:Production, means the output of Paints & Coatings Used ShellacRevenue, means the sales value of Paints & Coatings Used ShellacThis report studies Paints & Coatings Used Shellac in Global market,

USD 3500View Report

Fill The Form For Sample Request
Name*
Email*
Mobile No.*
LandLine No.
If you want to purchase particular section from this report then kindly contact us at contact@aarkstore.com.

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    $ 1290
  • CD    $ 1390
  • Hard Copy    $ 1440
  • Site Licence    $ 2090
  • Enterprise Wide Licence    $ 2090
$ 1290

Reports Details

Published Date : Aug 2015
No. of Pages :87
Country :Global
Category :Healthcare
Publisher :Renub Research
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

payment